NCT05992519View on ClinicalTrials.gov

Diagnostic and Translational Values of Point-of-care Blood Eosinophils and Exhaled Nitric Oxide (FeNO) in People Referred by Primary Care for Suspected Asthma

RecruitingOBSERVATIONAL
Enrollment

123

Participants

Timeline

Start Date

November 7, 2022

Primary Completion Date

November 1, 2026

Study Completion Date

November 1, 2026

Conditions
AsthmaAsthma in ChildrenDiagnosisInflammation
Interventions
DIAGNOSTIC_TEST

¸FeNO

FeNO measured with a NIOX VERO device after the methacholine challenge

Trial Locations (1)

J1H5N4

RECRUITING

Centre de Recherche du CHUS, Sherbrooke

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

Association Pulmonaire du Quebec

OTHER

collaborator

Réseau de Recherche en Santé Respiratoire du Québec

UNKNOWN

collaborator

AstraZeneca

INDUSTRY

collaborator

Fonds de la Recherche en Santé du Québec

OTHER_GOV

collaborator

Fondation JA DeSève

UNKNOWN

lead

Université de Sherbrooke

OTHER